Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks)
US8614215B2 · kind B2 · utility
1Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2008 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | Aug 7, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D451/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to quinoxaline compounds of Formula (I) in particular for the treatment of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.